These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19. Matsuzawa Y; Kimura K; Ogawa H; Tamura K Hypertens Res; 2022 Jul; 45(7):1147-1153. PubMed ID: 35581498 [TBL] [Abstract][Full Text] [Related]
23. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2. Hallaj S; Ghorbani A; Mousavi-Aghdas SA; Mirza-Aghazadeh-Attari M; Sevbitov A; Hashemi V; Hallaj T; Jadidi-Niaragh F Immunol Cell Biol; 2021 Feb; 99(2):192-205. PubMed ID: 32864784 [TBL] [Abstract][Full Text] [Related]
25. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury. Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866 [TBL] [Abstract][Full Text] [Related]
26. Renin-Angiotensin System Modulation in Adults With COVID-19-Reply. Self WH; DeClercq J; Orr M; JAMA; 2023 Aug; 330(7):664-665. PubMed ID: 37581675 [No Abstract] [Full Text] [Related]
27. COVID-19, Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Inhibition: Implications for Practice. Katsi V; Pavlidis G; Charalambous G; Tousoulis D; Toutouzas K Curr Hypertens Rev; 2022; 18(1):3-10. PubMed ID: 33475077 [TBL] [Abstract][Full Text] [Related]
28. The role of renin-angiotensin system in sepsis-associated acute kidney injury: mechanisms and therapeutic implications. Garcia B; Zarbock A; Bellomo R; Legrand M Curr Opin Crit Care; 2023 Dec; 29(6):607-613. PubMed ID: 37861190 [TBL] [Abstract][Full Text] [Related]
29. COVID-19 and renin-angiotensin system modulators: what do we know so far? de la Cruz A; Ashraf S; Vittorio TJ; Bella JN Expert Rev Cardiovasc Ther; 2020 Nov; 18(11):743-748. PubMed ID: 32842817 [TBL] [Abstract][Full Text] [Related]
30. Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic. Dworakowska D; Grossman AB J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633235 [TBL] [Abstract][Full Text] [Related]
31. Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach? Salgado DR; Rocco JR; Silva E; Vincent JL Expert Opin Ther Targets; 2010 Jan; 14(1):11-20. PubMed ID: 20001206 [TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 effects on the renin-angiotensin-aldosterone system, therapeutic implications. Ye Q; Lai EY; Luft FC; Persson PB; Mao J Acta Physiol (Oxf); 2021 Apr; 231(4):e13608. PubMed ID: 33350096 [No Abstract] [Full Text] [Related]
33. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities. Pang XC; Zhang HX; Zhang Z; Rinkiko S; Cui YM; Zhu YZ Molecules; 2020 Dec; 26(1):. PubMed ID: 33396184 [TBL] [Abstract][Full Text] [Related]
35. A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality. Camelo S; Latil M; Agus S; Dioh W; Veillet S; Lafont R; Dilda PJ Emerg Microbes Infect; 2021 Dec; 10(1):2256-2263. PubMed ID: 34783636 [TBL] [Abstract][Full Text] [Related]
36. Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients. Chen C; Wang F; Chen P; Jiang J; Cui G; Zhou N; Moroni F; Moslehi JJ; Ammirati E; Wang DW J Am Heart Assoc; 2020 Nov; 9(21):e017736. PubMed ID: 32807002 [TBL] [Abstract][Full Text] [Related]
37. Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives. Chiappalupi S; Salvadori L; Vukasinovic A; Donato R; Sorci G; Riuzzi F Life Sci; 2021 May; 272():119251. PubMed ID: 33636175 [TBL] [Abstract][Full Text] [Related]
38. The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy. Kouhpayeh S; Shariati L; Boshtam M; Rahimmanesh I; Mirian M; Esmaeili Y; Najaflu M; Khanahmad N; Zeinalian M; Trovato M; Tay FR; Khanahmad H; Makvandi P Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064039 [TBL] [Abstract][Full Text] [Related]
39. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know? Vitiello A; Ferrara F Eur J Pharmacol; 2020 Sep; 883():173373. PubMed ID: 32679185 [TBL] [Abstract][Full Text] [Related]
40. [Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers]. Mareev YV; Mareev VY Kardiologiia; 2020 Apr; 60(4):4-9. PubMed ID: 32394850 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]